Woolley Michael J, Reynolds Christopher A, Simms John, Walker Christopher S, Mobarec Juan Carlos, Garelja Michael L, Conner Alex C, Poyner David R, Hay Debbie L
Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
School of Biological Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, UK.
Biochem Pharmacol. 2017 Oct 15;142:96-110. doi: 10.1016/j.bcp.2017.07.005. Epub 2017 Jul 11.
Calcitonin gene-related peptide (CGRP) or adrenomedullin (AM) receptors are heteromers of the calcitonin receptor-like receptor (CLR), a class B G protein-coupled receptor, and one of three receptor activity-modifying proteins (RAMPs). How CGRP and AM activate CLR and how this process is modulated by RAMPs is unclear. We have defined how CGRP and AM induce Gs-coupling in CLR-RAMP heteromers by measuring the effect of targeted mutagenesis in the CLR transmembrane domain on cAMP production, modeling the active state conformations of CGRP and AM receptors in complex with the Gs C-terminus and conducting molecular dynamics simulations in an explicitly hydrated lipidic bilayer. The largest effects on receptor signaling were seen with H295A, I298A, L302A, N305A, L345A and E348A, F349A and H374A (class B numbering in superscript). Many of these residues are likely to form part of a group in close proximity to the peptide binding site and link to a network of hydrophilic and hydrophobic residues, which undergo rearrangements to facilitate Gs binding. Residues closer to the extracellular loops displayed more pronounced RAMP or ligand-dependent effects. Mutation of H374 to alanine increased AM potency 100-fold in the CGRP receptor. The molecular dynamics simulation showed that TM5 and TM6 pivoted around TM3. The data suggest that hydrophobic interactions are more important for CLR activation than other class B GPCRs, providing new insights into the mechanisms of activation of this class of receptor. Furthermore the data may aid in the understanding of how RAMPs modulate the signaling of other class B GPCRs.
降钙素基因相关肽(CGRP)或肾上腺髓质素(AM)受体是降钙素受体样受体(CLR,一种B类G蛋白偶联受体)与三种受体活性修饰蛋白(RAMP)之一形成的异聚体。CGRP和AM如何激活CLR以及该过程如何被RAMP调节尚不清楚。我们通过测量CLR跨膜结构域中的定点诱变对cAMP产生的影响、对与Gs C末端复合的CGRP和AM受体的活性状态构象进行建模以及在明确水合的脂质双层中进行分子动力学模拟,确定了CGRP和AM如何在CLR-RAMP异聚体中诱导Gs偶联。对受体信号传导影响最大的是H295A、I298A、L302A、N305A、L345A和E348A、F349A以及H374A(上标为B类编号)。这些残基中的许多可能形成靠近肽结合位点的一组的一部分,并连接到亲水性和疏水性残基网络,这些残基会发生重排以促进Gs结合。更靠近细胞外环的残基表现出更明显的RAMP或配体依赖性效应。将H374突变为丙氨酸可使CGRP受体中的AM效力提高100倍。分子动力学模拟表明,TM5和TM6围绕TM3旋转。数据表明,疏水相互作用对CLR激活比其他B类GPCR更重要,为这类受体的激活机制提供了新见解。此外,这些数据可能有助于理解RAMP如何调节其他B类GPCR的信号传导。